Royalty Pharma plc
RPRX
株式のランク
#893
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
株価
$60.39
最終同期: 2026-10-19
時価総額
$26.89B
変化（1日）
-0.93%
変化（1年）
64.87%
国
US
取引 Royalty Pharma plc (RPRX)
カテゴリー
Healthcare
Royalty Pharma plc（RPRX）の配当利回りの履歴
Royalty Pharma plc（銘柄コード: RPRX）の配当利回り（TTM）は2023-12-31時点で2.85%です。
過去5年間の平均配当利回り: 2.37%
過去5年間の平均配当利回り: 2.37%
Royalty Pharma plc（RPRX）の2015から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
|
| 0.00% |
US
|
